Brief: Cipla Launches Yurpeak For Obesity And Type 2 Diabetes
10/12/2025 11:42
Dec 10 (Reuters) - Cipla Ltd CIPL.NS: CIPLA - LAUNCHES YURPEAK FOR OBESITY AND TYPE 2 DIABETES CIPLA - TO DISTRIBUTE YURPEAK IN INDIA AFTER DCGI APPROVAL Source text: ID:nBSE2SmsNV Further company coverage: CIPL.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Cipla
See all newsFactbox: Global healthcare companies invest billions to boost US presence
Brief: Cipla, Qilu Pharmaceutical Partner For Licensing, Supply Of Biosimilar To Keytruda In US
India's Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar
Brief: Cipla Enters Exclusive Partnership With Qilu For Keytruda Biosimilar In US
Brief: Cipla and SBP Group Sign Exclusive Licensing Agreement For HER2 Bispecific Antibody-Drug Conjugate